Dehydroepiandrosterone enanthate
Dehydroepiandrosterone enanthate has been studied in 1 paper since 1981: 1 trial in people. The newest paper, Dec 1, 1981: “Catabolic effects and the influence on hormonal variables under treatment with Gynodian-Depot or dehydroepiandrosterone (DHEA) oenanthate”.
See all 1 papers on dehydroepiandrosterone enanthate
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“An average weight loss of greater than 1 kg/mth was observed under DHEA treatment in 7 out of 15 adipose cases.”
None of its findings points the other way.
- 1 lab in 1 country
- Human trial1
Studies in people
1 study gave dehydroepiandrosterone enanthate to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
down: Decreases body weightAverage weight loss >1 kg/month in 7 of 15 cases up: Increases low-polar estrogen excretion4 of 13 cases | Trial | 15 peopleWomenpostmenopausalPostmenopausal women; Weight loss observed in 7 of 15 patients with obesity | Maturitas, Dec 1, 1981 |
What did studies of dehydroepiandrosterone enanthate find?
2Studies of dehydroepiandrosterone enanthate measured 2 outcomes; the most studied are low-polar estrogen excretion (1 study) and body weight (1).
Low-polar estrogen excretion
upin humans1
1 study
Low-polar estrogen excretion
upin humans1
Dehydroepiandrosterone enanthate increases low-polar estrogen excretion in humans (Increase observed in 4 of 13 cases) (4 of 13 cases).
“The elimination of low-polar oestrogens increased considerably in 4 out of 13 post-menopausal cases treated with DHEA.”
Human trialIncrease observed in 4 of 13 casesoenanthate200 mg monthlyfemalesn = 13
Maturitas
Body weight
downin humans1
1 study
Body weight
downin humans1
Dehydroepiandrosterone enanthate decreases body weight in humans (Weight loss observed in 7 of 15 patients with obesity) (Average weight loss >1 kg/month in 7 of 15 cases).
“An average weight loss of greater than 1 kg/mth was observed under DHEA treatment in 7 out of 15 adipose cases.”
Human trialWeight loss observed in 7 of 15 patients with obesityoenanthate200 mg monthlyn = 15
Maturitas